Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences Point-of-Care Diagnostics World Congress

James Herron's Biography

James Herron, Associate Professor, University Of Utah

Dr. Herron received a B.S. degree in Biology, and M.S. and Ph.D. degrees in Microbiology from the University of Illinois at Urbana-Champaign. He undertook postdoctoral training at the University of Utah in structure biology and later in optical biosensor technology. Dr. Herron is interested in translational research – specifically, translating innovative near-patient diagnostics technologies from the laboratory into the clinic. Presently, his research is focused in three areas: 1) optical biosensor applications in biodefense, diagnostics, companion diagnostics, environmental and food testing, and personalized medicine; 2) high-throughput homogeneous fluorescence assays for use in biodefense, diagnostics, and quality control and assurance; and 3) dynamic light scattering as a means of detecting intravenous (IV) drug incompatibilities, when co-administered through the same IV line. He has published 113 full-length research articles and 107 abstracts. He also edited a book entitled “Physical Methods to Characterize Pharmaceutical Proteins.”

James Herron Image

Waveguide-based Microarray Technology for Rapid, Inexpensive, Multiplex Diagnostics Assays

Friday, 19 September 2014 at 17:45

Add to Calendar ▼2014-09-19 17:45:002014-09-19 18:45:00Europe/LondonWaveguide-based Microarray Technology for Rapid, Inexpensive, Multiplex Diagnostics AssaysPoint-of-Care Diagnostics World Congress in San Diego, California, USASan Diego, California,

In-plane parallel scanning (IPPS) is an innovative microarray technology for rapid, inexpensive, multiplex diagnostics assays. It replaces expensive laser scanning with a grid of 100 µm-wide waveguides embedded in the chip’s substrate enabling real-time quantification of molecular complex formation on the chip’s surface.  Compared to conventional microarray technology, IPPS offers advantages of shorter assay time and lower instrument cost and complexity so that the platform can potentially be used in point-of-care (POC) settings. Two different chip formats have been developed: a low-density microarray with 10 sensing wells and a medium-density one with 100 sensing wells. Sub- to low-picomolar performance has been observed in several different clinical immunoassays using this technology.

Add to Calendar ▼2014-09-18 00:00:002014-09-19 00:00:00Europe/LondonPoint-of-Care Diagnostics World CongressPoint-of-Care Diagnostics World Congress in San Diego, California, USASan Diego, California,